Browse Blood products topic

Subtopics (14)

• Analysis
• Cases
• Economic aspects
• Government finance
• Health aspects
• History
• Labeling
• Laws, regulations and rules
• Marketing
• Prices and rates
• Quality management
• Statistics
• Supply and demand
• Usage

Articles

Title	Author	Type	Date	Words
Application of Six Sigma/CAP methodology: controlling blood-product utilization and costs.	Neri, Robert A.; Mason, Cindy E.; Demko, Lisa A.; Mazer, Sherry		May 1, 2008	4913
Successful use of a polymerized hemoglobin blood substitute in a critically anemic Jehovah's Witness.	Feeney, Colin		Dec 1, 2004	1210
Armful practice? The National Blood Authority has radically changed its problematic cost allocation method for joint blood products, but the new approach is equally flawed--if not more so. Paul Trenchard and Rob Dixon report on their CIMA-funded project to develop a third way based on the usefulness of products rather than profitability.	Trenchard, Paul; Dixon, Rob		Apr 1, 2004	1324
Table of reference intervals.		Illustration	Aug 1, 2003	1234
Companies knowingly sold virus-tainted blood products abroad, class action claims.	Moen, Christian Harlan		Aug 1, 2003	663
FDA proposes bar codes for drugs, blood products. (Effort to Reduce Medication Errors).	Sullivan, Michele G.		May 1, 2003	373
Blood work: scientists seek to identify all the proteins in plasma.	Travis, John		Mar 15, 2003	1739
Platelet supplier required to stop paying for blood. (Up Front).	Darmiento, Laurence	Brief Article	Sep 2, 2002	393
American Red Cross Raises Blood Prices.	Friedman, Mark	Brief Article	Jul 9, 2001	160
Japanese blood scandal perpetrators sentenced.		Brief Article	Apr 1, 2000	115
Lab industry opposes Clinton plan to reinstate co-pay for lab services; GAO to study safety and supply of nation's blood.	Szabo, Joan	Column	Sep 1, 1999	775
Implementing the ISBT 128 labeling standard in a transfusion service.	Tiehen, Ann; Swanson, Sandra	Cover Story	May 1, 1998	2868
Discarded blood could be put to good use, say experts.	Brown, Edwin W.		Dec 1, 1997	422
Audit notice, 483 notations not in store for biologics; 510(k) inspections to wane.		Brief Article	Oct 1, 1997	320
Team finds problems with RhoGAM, IVD production.		Brief Article	Oct 1, 1997	501
Mayo blood bank advice all verbal; no 483 issued.		Brief Article	Oct 1, 1997	419
HIV-infected hemophiliacs consider settlement offer.	Dilworth, Donald C.		Oct 1, 1996	577
Bad blood: contaminated plasma sickens users of Gammaguard.	Shoop, Julie Gannon		Sep 1, 1995	959